The findings and conclusions in these presentations have not been formally disseminated by the Centers for Disease Control and Prevention and should not be construed to represent any agency determination or policy.

Williford C
Wednesday, March 12, 2008: 10:15 AM-12:00 PM

C5: Evolving Challenges for the Laboratory Diagnosis of Sexually Transmitted Diseases

Organizer:John R. Papp
Moderator:John R. Papp
 
Summary: Background/Purpose: Technologic advances have spurred significant improvements for clinical laboratory services including greater flexibility in etiologic detection and result reporting. Clinical laboratories may develop tests for rapid detection of emergent pathogens or incorporate new test marketed for endemic pathogens. Despite this array, mutations in organisms may adversely affect detection.

Objectives of Symposium: Highlight key developments do improve or hinder the laboratory diagnosis of sexually transmitted diseases.

Implications for Programs, Policy, and/or Research: Providers and disease control officials would garner information on a wide variety of bacterial and viral sexually transmitted diseases. This will be particularly useful developing or augmenting existing disease control programs.

 
10:15 AMImplications of the variant strain of Chlamydia trachomatis (CT) circulating in Sweden
Charlotte A. Gaydos
10:35 AMReal-time PCR as a tool for surveillance for L-serovars of Chlamydia trachomatis (the cause of Lymphogranuloma Venereum) in San Francisco
Mark Pandori
10:55 AMDiagnosis of genital ulcer disease by PCR
Chen Y. Cheng
11:15 AMDetection of syphilis and HSV in MSM
Anne Rompalo
11:35 AMNew Technologies in Cervical Cancer Screening
Cosette Wheeler

The 2008 National STD Prevention Conference of CDC